IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CECI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.855
AS - Asia 1.639
NA - Nord America 1.201
SA - Sud America 153
AF - Africa 36
OC - Oceania 14
Totale 4.898
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.144
DE - Germania 1.072
CN - Cina 558
SG - Singapore 459
IT - Italia 339
HK - Hong Kong 196
BR - Brasile 113
BD - Bangladesh 100
RU - Federazione Russa 100
FR - Francia 80
NL - Olanda 71
IN - India 69
VN - Vietnam 67
GB - Regno Unito 38
JP - Giappone 35
CA - Canada 32
ID - Indonesia 32
KR - Corea 32
ES - Italia 31
FI - Finlandia 30
SE - Svezia 28
TR - Turchia 17
IR - Iran 14
MX - Messico 14
AT - Austria 11
AU - Australia 11
CH - Svizzera 10
TW - Taiwan 10
EC - Ecuador 9
IQ - Iraq 9
PL - Polonia 9
ZA - Sudafrica 9
CI - Costa d'Avorio 8
CO - Colombia 8
VE - Venezuela 7
AR - Argentina 6
IE - Irlanda 6
MY - Malesia 6
UA - Ucraina 6
BE - Belgio 5
KZ - Kazakistan 5
MA - Marocco 4
PH - Filippine 4
PK - Pakistan 4
TH - Thailandia 4
BG - Bulgaria 3
CL - Cile 3
JO - Giordania 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
FJ - Figi 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
LU - Lussemburgo 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
KW - Kuwait 1
MN - Mongolia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TV - Tuvalu 1
Totale 4.898
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.002
Singapore 210
Ashburn 201
Hong Kong 166
San Jose 110
Dallas 107
Milan 92
Hefei 90
Beijing 76
Los Angeles 54
Santa Clara 54
New York 43
Bengaluru 37
Council Bluffs 36
Buffalo 27
Lauterbourg 27
Jakarta 26
Guangzhou 25
Moscow 25
Munich 25
Rome 25
Helsinki 18
Nuremberg 18
Tokyo 18
Hanoi 16
Ho Chi Minh City 16
Shanghai 15
Chicago 14
Atlanta 13
Boardman 13
Hangzhou 13
Madrid 13
Naples 13
Seattle 13
Seoul 13
Wuhan 13
Columbus 12
Hyderabad 12
Florence 11
London 10
São Paulo 10
Yongin-si 10
Bologna 9
Abidjan 8
Bari 8
Cangzhou 8
Istanbul 8
Turin 8
Vienna 8
Barcelona 7
Houston 7
Orem 7
San Francisco 7
Shenzhen 7
Southend 7
Sydney 7
Toronto 7
Washington 7
Ürümqi 7
Andorno Micca 6
Boston 6
Brooklyn 6
Chandler 6
Haiphong 6
Monza 6
Philadelphia 6
Tehran 6
Warsaw 6
Arlington 5
Bogotá 5
Da Nang 5
Dhaka 5
Dublin 5
Groningen 5
Johannesburg 5
Lappeenranta 5
Media 5
Montreal 5
Nanjing 5
Quito 5
Sacramento 5
Tianjin 5
Zurich 5
Almaty 4
Berlin 4
Caracas 4
Denver 4
Dong Ket 4
Hamburg 4
Kuala Lumpur 4
Modena 4
Mumbai 4
Nijmegen 4
Palermo 4
Paris 4
Phoenix 4
Princeton 4
Rio de Janeiro 4
Rockville 4
Silver Spring 4
Totale 3.066
Salva come PNG Salva come JPEG
Nome #
[¹⁸ F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma [$\less$sup$\greater$18$\less$/sup$\greater$F]-{FDG} {PET} radiomic model as prognostic biomarker in diffuse large B-cell lymphoma] 362
Automatic Segmentation with Deep Learning in Radiotherapy 324
Lung uptake detected by 68Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case series 259
{PSMA} {PET}/{CT}: joint {EANM} procedure guideline/{SNMMI} procedure standard for prostate cancer imaging 2.0 255
Diagnostic Accuracy of Ga-68-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection A Multicenter Prospective Phase 3 Imaging Trial 248
Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET 248
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL 231
Radiolabeled FAP inhibitors as new pantumoral radiopharmaceuticals for PET imaging: a pictorial essay 218
First Live-Experience Session with PET/CT Specimen Imager: A pilot analysis in Prostate Cancer and Neuroendocrine Tumor 206
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature 204
Metastasis-free survival and patterns of distant metastatic disease after PSMA-PET-guided salvage radiotherapy in recurrent or persistent prostate cancer after prostatectomy 187
Global attitudes in the management of acute appendicitis during COVID-19 pandemic: ACIE Appy Study 185
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence 182
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas 174
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models 172
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy 162
Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology 143
How to Report {PSMA} {PET} 140
Prostate-specific membrane antigen (PSMA) radioguided surgery in prostate cancer: An overview of current application and future perspectives 137
Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET/CT images of neuroendocrine tumor 135
Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence 130
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis 124
Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer 117
Comparison of different algorithms for the conversion of RTSS file into binary mask for SPECT-based 177Lu-peptide kidney dosimetry: impact on kidneys’ volume and absorbed dose 99
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review 98
A PET‐Surrogate Signature for the Interrogation of the Metabolic Status of Breast Cancers 82
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis 72
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : : Nodal oligorecurrent prostate cancer 64
C-11-Choline PET/CT and Bladder Cancer Lymph Node Metastasis Assessment With Pathological Specimens as Reference Standard 63
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study 7
null 3
null 3
Totale 5.034
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/202234 1 2 2 2 2 0 2 2 13 4 0 4
2022/2023155 3 0 1 6 7 15 10 25 14 15 32 27
2023/20241.168 37 25 35 50 123 72 171 131 75 138 152 159
2024/20251.226 144 123 125 128 64 49 54 77 54 93 91 224
2025/20262.430 229 230 327 173 227 103 246 76 218 127 323 151
Totale 5.034